150 related articles for article (PubMed ID: 36011395)
1. Circular Noncoding RNA hsa_circ_0003570 as a Prognostic Biomarker for Hepatocellular Carcinoma.
Jang SY; Kim G; Tak WY; Kweon YO; Lee YR; Han YS; Han JR; Park JG; Kang MK; Lee HW; Lee WK; Park SY; Hur K
Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011395
[TBL] [Abstract][Full Text] [Related]
2. Circular noncoding RNA hsa_circ_0005986 as a prognostic biomarker for hepatocellular carcinoma.
Kim G; Han JR; Park SY; Tak WY; Kweon YO; Lee YR; Han YS; Park JG; Kang MK; Lee HW; Lee WK; Kim D; Jang SY; Hur K
Sci Rep; 2021 Jul; 11(1):14930. PubMed ID: 34294754
[TBL] [Abstract][Full Text] [Related]
3. Tissue Circular RNA_0004018 and 0003570 as Novel Prognostic Biomarkers for Hepatitis B-Related Hepatocellular Carcinoma.
Kang MK; Kim G; Park JG; Jang SY; Lee HW; Tak WY; Kweon YO; Park SY; Lee YR; Hur K
Genes (Basel); 2023 Oct; 14(10):. PubMed ID: 37895312
[TBL] [Abstract][Full Text] [Related]
4. Circular RNA 0068669 as a new biomarker for hepatocellular carcinoma metastasis.
Yao T; Chen Q; Shao Z; Song Z; Fu L; Xiao B
J Clin Lab Anal; 2018 Oct; 32(8):e22572. PubMed ID: 29785842
[TBL] [Abstract][Full Text] [Related]
5. Hsa_circ_0028502 and hsa_circ_0076251 are potential novel biomarkers for hepatocellular carcinoma.
Jiang Z; Shen L; Wang S; Wu S; Hu Y; Guo J; Fu L
Cancer Med; 2019 Dec; 8(17):7278-7287. PubMed ID: 31595711
[TBL] [Abstract][Full Text] [Related]
6. Circular RNA hsa_circ_0000437 may be used as a new indicator for the diagnosis and prognosis of hepatocellular carcinoma.
Chen G; Xie D; Zhang P; Zhou H
Bioengineered; 2022 Jun; 13(6):14118-14124. PubMed ID: 35730467
[TBL] [Abstract][Full Text] [Related]
7. [Circular RNA hsa_circ_0006834 is a potential prognostic biomarker for hepatocellular carcinoma].
Zhang L; Zhao C; Xu Y; Chen Y; Cai Z; Lin H; Cai Q
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Nov; 43(11):1850-1856. PubMed ID: 38081601
[TBL] [Abstract][Full Text] [Related]
8. Global microarray profiling identified
Weng Q; Chen M; Li M; Zheng YF; Shao G; Fan W; Xu XM; Ji J
J Med Genet; 2019 Jan; 56(1):32-38. PubMed ID: 30120213
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide identification and characterization of circular RNA in resected hepatocellular carcinoma and background liver tissue.
Sunagawa Y; Yamada S; Sonohara F; Kurimoto K; Tanaka N; Suzuki Y; Inokawa Y; Takami H; Hayashi M; Kanda M; Tanaka C; Nakayama G; Koike M; Kodera Y
Sci Rep; 2021 Mar; 11(1):6016. PubMed ID: 33727578
[TBL] [Abstract][Full Text] [Related]
10. Circular RNAs hsa_circ_0001438 and hsa_circ_0000417 are downregulated and upregulated, respectively, in hepatocellular carcinoma.
Imanishi S; Nagata S; Fujita T; Fujii H
Int J Exp Pathol; 2022 Dec; 103(6):245-251. PubMed ID: 36153641
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of hsa_circ_0003570 in hepatocellular carcinoma and its clinical significance.
Fu L; Wu S; Yao T; Chen Q; Xie Y; Ying S; Chen Z; Xiao B; Hu Y
J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28493512
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of hsa_circ_0002003 promotes hepatocellular carcinoma progression.
Zhou L; Wang Q; Hou J; Wu X; Wang L; Chen X
BMC Cancer; 2023 Jul; 23(1):611. PubMed ID: 37400785
[TBL] [Abstract][Full Text] [Related]
13. Circular RNA Hsa_Circ_0091579 Serves as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma.
Zhang C; Zhang C; Lin J; Wang H
Cell Physiol Biochem; 2018; 51(1):290-300. PubMed ID: 30453307
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA hsa_circ_0006091 as a novel biomarker for hepatocellular carcinoma.
Zhang Y; Li J; Cui Q; Hu P; Hu S; Qian Y
Bioengineered; 2022 Feb; 13(2):1988-2003. PubMed ID: 35068348
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Circular RNA Profiling Reveals That hsa_circ_0005075, a New Circular RNA Biomarker, Is Involved in Hepatocellular Crcinoma Development.
Shang X; Li G; Liu H; Li T; Liu J; Zhao Q; Wang C
Medicine (Baltimore); 2016 May; 95(22):e3811. PubMed ID: 27258521
[TBL] [Abstract][Full Text] [Related]
16. Dysregulated circ_0004913, circ_0008160, circ_0000517, and their potential as biomarkers for disease monitoring and prognosis in hepatocellular carcinoma.
Li X; Yang J; Yang X; Cao T
J Clin Lab Anal; 2021 Jun; 35(6):e23785. PubMed ID: 34018640
[TBL] [Abstract][Full Text] [Related]
17. Hsa_circ_0005986 inhibits carcinogenesis by acting as a miR-129-5p sponge and is used as a novel biomarker for hepatocellular carcinoma.
Fu L; Chen Q; Yao T; Li T; Ying S; Hu Y; Guo J
Oncotarget; 2017 Jul; 8(27):43878-43888. PubMed ID: 28410211
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic hsa_circ_0091581 promotes the malignancy of HCC cell through blocking miR-526b from degrading c-MYC mRNA.
Wei X; Zheng W; Tian P; He Y; Liu H; Peng M; Li X; Liu X
Cell Cycle; 2020 Apr; 19(7):817-824. PubMed ID: 32116112
[TBL] [Abstract][Full Text] [Related]
19. Serum hsa_circ_0000615 is a prognostic biomarker of sorafenib resistance in hepatocellular carcinoma.
Zhang L; Xu T; Li Y; Pang Q; Ding X
J Clin Lab Anal; 2022 Nov; 36(11):e24741. PubMed ID: 36268976
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA 0016788 displays as a biomarker for tumor progression and poor prognosis in surgical hepatocellular carcinoma patients.
Cheng F; Wang L; Zhang J
J Clin Lab Anal; 2020 Jul; 34(7):e23300. PubMed ID: 32319701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
